19235-17-7

19235-17-7 structure

Name: 5-HydroxyMethyl cytidine
Chemical Name: 5-hydroxymethyl-1-(β-D-ribofuranosyl)cytosine
CAS Number: 19235-17-7
Molecular Formula: C₁₀H₁₅N₃O₆
Molecular Weight: 273.24
Catalog: Signaling Pathways Cell Cycle/DNA Damage Nucleoside Antimetabolite/Analog
Create Date: 2016-04-02 13:25:51
Modify Date: 2026-07-01 10:33:57
5-(Hydroxymethyl)cytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

Name	5-hydroxymethyl-1-(β-D-ribofuranosyl)cytosine
Synonyms	5-Hydroxymethyl cytidine, RNA modified nucleoside, hm5C 4-Amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(hydroxymethyl)pyrimidin-2(1H)-one 5-Hydroxymethylcytidine Cytidine, 5-(hydroxymethyl)

Description	5-(Hydroxymethyl)cytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog	Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog Research Areas >> Others
References	[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.